|  Help  |  About  |  Contact Us

Publication : Characterization of cognitive deficits in mice with an alternating hemiplegia-linked mutation.

First Author  Kirshenbaum GS Year  2015
Journal  Behav Neurosci Volume  129
Issue  6 Pages  822-31
PubMed ID  26501181 Mgi Jnum  J:250056
Mgi Id  MGI:6102222 Doi  10.1037/bne0000097
Citation  Kirshenbaum GS, et al. (2015) Characterization of cognitive deficits in mice with an alternating hemiplegia-linked mutation. Behav Neurosci 129(6):822-31
abstractText  Cognitive impairment is a prominent feature in a range of different movement disorders. Children with Alternating Hemiplegia of Childhood are prone to developmental delay, with deficits in cognitive functioning becoming progressively more evident as they grow older. Heterozygous mutations of the ATP1A3 gene, encoding the Na+,K+-ATPase alpha3 subunit, have been identified as the primary cause of Alternating Hemiplegia. Heterozygous Myshkin mice have an amino acid change (I810N) in Na+,K+-ATPase alpha3 that is also found in Alternating Hemiplegia. To investigate whether Myshkin mice exhibit learning and memory deficits resembling the cognitive impairments of patients with Alternating Hemiplegia, we subjected them to a range of behavioral tests that interrogate various cognitive domains. Myshkin mice showed impairments in spatial memory, spatial habituation, locomotor habituation, object recognition, social recognition, and trace fear conditioning, as well as in the visible platform version of the Morris water maze. Increasing the duration of training ameliorated the deficit in social recognition but not in spatial habituation. The deficits of Myshkin mice in all of the learning and memory tests used are consistent with the cognitive impairment of the vast majority of AHC patients. These mice could thus help advance our understanding of the underlying neural mechanisms influencing cognitive impairment in patients with ATP1A3-related disorders.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression